Anna Thor

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BJU INTERNATIONAL. 2024;133(6):717-724
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
Gerdtsson A; Negaard HFS; Almas B; Bergdahl AG; Cohn-Cedermark G; Glimelius I; Halvorsen D; Haugnes HS; Hedlund A; Hellstrom M; Holmberg G; Karlsdottir A; Kjellman A; Larsen SM; Thor A; Wahlqvist R; Stahl O; Tandstad T
Journal article: INVESTIGATIVE UROLOGY. 2024;211(5S):e4
MP01-08 MicroRNA-371a-3p (miR371a) SERUM LEVELS TO PREDICT THE PRESENCE OF METASTATIC LYMPH NODES IN MARKER NEGATIVE CLINICAL STAGE IIA/B SEMINOMA
Heidenreich A; Thor A; Kjellmann A; Bergdahl AG; Myklebust M-P; Bragodia A; Laffin J; Konneh B; Seelemeyer F; Pfister D
Article: CURRENT ONCOLOGY. 2024;31(2):933-940
Ablative or Surgical Treatment for Small Renal Masses (T1a): A Single-Center Comparison of Perioperative Morbidity and Complications
Radros J; Kjellman A; Henningsohn L; Forslin Y; Delle M; Hrebenyuk M; Thor A; Thiel T; Hermann M; Lundgren P-O
Article: BJU INTERNATIONAL. 2023;132(3):329-336
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
Gerdtsson A; Torisson G; Thor A; Bergdahl AG; Almas B; Hakansson U; Tornblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269
Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders
Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KEE; Pettersson A; Glimelius I
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):5008
Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne.
Tandstad T; Kjellman A; Almås B; Grenabo Bergdahl A; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Journal article: INVESTIGATIVE UROLOGY. 2023;209(Supplement 4):e451
MP33-04 THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3cm
Thor A; Gerdtsson A; Almas B; Halvorsen D; Cedermark GC; Neegaard H; Glimelius I; Haugnes HS; Karlsdottir A; Stahl O; Larsen SM; Bergdahl AG; Tandstad T; Kjellman A
Journal article: EUROPEAN UROLOGY. 2023;83:s1072
Low rate of teratoma in primary retroperitoneal lymph node dissection for non-seminoma csiia marker negative patients - a population-based study from the swedish and norwegian testicular cancer group
Gerdtsson A; Thor AT; Grenabo BAGB; Almas BA; Negaard HF; Glimelius I; Halvorsen DH; Karlsdottir AK; Haugnes HSH; Larsen SML; Holmberg GH; Wahlqvist RW; Tandstad TT; Cohn-Cedermark GCC; Kjellman AK; Stahl OS
Journal article: EUROPEAN UROLOGY. 2023;83:s1068
The early results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) introduction of primary Retroperitoneal Lymph Node Dissection (RPLND) in seminoma stage IIA-IIb ≤ 3cm
Thor A; Grenabo BA; Almas B; Halvorsen D; Cohn CG; Neegaard H; Karlsdottir A; Sagstuen HH; Stahl O; Gerdtsson A; Melsen LS; Tandstad T; Kjellman A
Journal article: INVESTIGATIVE UROLOGY. 2022;207(Supplement 5):e845
PD51-07 PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)
Gerdtsson A; Thor A; Bergdahl AG; Negaard H; Almås B; Glimelius I; Karlsdottir Å; Halvorsen D; Andreassen KE; Larsen SM; Wahlqvist R; Haugnes HS; Tandstad T; Holmberg G; Cedermark GC; Ståhl O; Thorison G; Kjellman A
Article: EUROPEAN UROLOGY ONCOLOGY. 2022;5(2):235-243
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Gerdtsson A; Thor A; Bergdahl AG; Almas B; Hakansson U; Tornblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A
Article: CANCER GENOMICS AND PROTEOMICS. 2022;19(2):178-193
MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer
Myklebust MP; Soviknes AM; Halvorsen OJ; Thor A; Dahl O; Raeder H
Article: SCIENTIFIC REPORTS. 2021;11(1):15582
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Myklebust MP; Thor A; Rosenlund B; Gjengsto P; Karlsdottir A; Brydoy M; Bercea BS; Olsen C; Johnson I; Berg MI; Langberg CW; Andreassen KE; Kjellman A; Haugnes HS; Dahl O
Journal article: INVESTIGATIVE UROLOGY. 2020;203:e384
PD19-06 LOCATION AND HISTOLOGY OF RETROPERITONEAL METASTASES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMA GERM CELL TUMOUR
Gerdtsson A; Thor* A; Grenabo A; Almås B; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
Article: PLOS ONE. 2014;9(8):e103932
Cascade Bioassay Evidence for the Existence of Urothelium-Derived Inhibitory Factor in Guinea Pig Urinary Bladder
Guan NN; Thor A; Hallen K; Wiklund NP; Gustafsson LE

Alla övriga publikationer

Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
Primary retroperitoneal lymph node dissection (RPLND) in seminoma stage IIA-IIC ≤3cm: Combined results of the SWENOTECA (Swedish Norwegian Testicular Cancer Group) and Cologne
Tandstad T; Kjellman A; Almas B; Bergdahl AG; Cohn-Cedermark GE; Gerdtsson A; Glimelius I; Halvorsen DL; Haugnes HSS; Hedlund A; Karlsdottir A; Larsen SM; Negaard HFS; Pfister D; Stahl O; Thor A; Wahlquist R; Heidenreich A; Paffenholz P; Seelemeyer F
Conference publication: JOURNAL OF UROLOGY. 2023;209:E451
THE EARLY RESULTS OF THE SWENOTECA (SWEDISH NORWEGIAN TESTICULAR CANCER GROUP) INTRODUCTION OF PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) IN SEMINOMA STAGE IIA-IIB ≤ 3CM
Thor A; Gerdtsson A; Almas B; Halvorsen D; Cedermark GC; Neegaard H; Glimelius I; Haugnes HS; Karlsdottir A; Stahl O; Larsen SM; Bergdahl AG; Tandstad T; Kjellman A
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S777
Risk and mortality of testicular cancer in patients with psychiatric or neurodevelopmental disorders
Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KE; Pettersson A; Glimelius I
Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E845
PREDICTING THE HISTOPATHOLOGY RESULT OF POST-CHEMO RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND)
Gerdtsson A; Thor A; Bergdahl AG; Negaard H; Almas B; Glimelius I; Karlsdottir A; Halvorsen D; Andreassen KE; Larsen SM; Wahlqvist R; Haugnes HS; Tandstad T; Holmberg G; Cedermark GC; Stahl O; Thorison G; Kjellman A
Conference publication: JOURNAL OF UROLOGY. 2020;203:E384
LOCATION AND HISTOLOGY OF RETROPERITONEAL METASTASES IN POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR NON-SEMINOMA GERM CELL TUMOUR
Gerdtsson A; Thor A; Grenabo A; Almas B; Negaard HFS; Glimelius I; Halvorsen D; Karlsdottir A; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Stahl O; Kjellman A

Anställningar

Doktorand, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2024

Examina och utbildning

Läkarexamen, Karolinska Institutet, 2005

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI